David Löfgren

Statistics

Publications

Citations

188

H-Index

Active since

1991

Affiliations

Science for Life Laboratory(Current)

Ryhov Hospital Jönköping

Örebro University

Sahlgrenska University Hospital

Linköping University Hospital

David Löfgren is an author at Science for Life Laboratory specializing in glioblastoma chemotherapy, combination chemotherapy, and glioblastoma clinical trials.

ORCID

Publications per year

1991–2023

Publications

A prospective follow-up study of so-called borderline children

David Löfgren, Jules R. Bemporad, Jacob D. King et al. · American Journal of Psychiatry · 1991 · 93 citations

Social Sciences, Psychiatry, Psychology +17

Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma

Katja Werlenius, Sara Kinhult, Tora S. Solheim et al. · JAMA Network Open · 2023 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial

Asgeir Store Jakola, Katja Werlenius, Munila Mudaisi et al. · F1000Research · 2018 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

Risk for morbidity and mortality after neurosurgery in older patients with high grade gliomas – a retrospective population based study

David Löfgren, Antonios Valachis, Magnus Olivecrona · BMC Geriatrics · 2022 · 10 citations · Full text

Medicine, Neurosurgery, Surgery +17

1–4 of 4